Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis

Table 1

Characteristics of breast cancer patients and control groups: benign breast tumor and healthy women.

Study group		Number of patients
Tested group	Breast cancer patients	120
	Ductal adenocarcinoma	120
	Median age (range)	54 (34–72)
	Tumor stage
	I	29
	II	30
	III	31
	IV	30
	Menopausal status
	(i) Premenopausal	51
	(ii) Postmenopausal	69
Control group	Benign breast tumor patients	60
	Adenoma	21
	Intraductal papilloma	18
	Fibroadenoma	11
	Mastopatia	10
	Median age (range)	44 (26–71)
	Menopausal status
	(i) Premenopausal	29
	(ii) Postmenopausal	31
	Healthy women	60
	Median age (range)	48 (23–73)
	Menopausal status
	(i) Premenopausal	26
	(ii) Postmenopausal	34